[go: up one dir, main page]

SE424184B - PROCEDURE FOR PREPARING PEPTIDES WITH POWERFUL LH-RH / FSH-RH EFFECTS - Google Patents

PROCEDURE FOR PREPARING PEPTIDES WITH POWERFUL LH-RH / FSH-RH EFFECTS

Info

Publication number
SE424184B
SE424184B SE7508926A SE7508926A SE424184B SE 424184 B SE424184 B SE 424184B SE 7508926 A SE7508926 A SE 7508926A SE 7508926 A SE7508926 A SE 7508926A SE 424184 B SE424184 B SE 424184B
Authority
SE
Sweden
Prior art keywords
fsh
powerful
procedure
effects
preparing peptides
Prior art date
Application number
SE7508926A
Other languages
Swedish (sv)
Other versions
SE7508926L (en
Inventor
W Konig
R Geiger
J K Sandow
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7508926L publication Critical patent/SE7508926L/en
Publication of SE424184B publication Critical patent/SE424184B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7508926A 1974-08-09 1975-08-07 PROCEDURE FOR PREPARING PEPTIDES WITH POWERFUL LH-RH / FSH-RH EFFECTS SE424184B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438350A DE2438350C3 (en) 1974-08-09 1974-08-09 Peptides with a strong LH-RH / FSH-RH action, process for their production and pharmaceutical preparations containing them

Publications (2)

Publication Number Publication Date
SE7508926L SE7508926L (en) 1976-02-10
SE424184B true SE424184B (en) 1982-07-05

Family

ID=5922833

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7508926A SE424184B (en) 1974-08-09 1975-08-07 PROCEDURE FOR PREPARING PEPTIDES WITH POWERFUL LH-RH / FSH-RH EFFECTS
SE7805545A SE7805545L (en) 1974-08-09 1978-05-16

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7805545A SE7805545L (en) 1974-08-09 1978-05-16

Country Status (15)

Country Link
US (1) US4024248A (en)
JP (1) JPS5761268B2 (en)
AT (1) AT364093B (en)
BE (1) BE832310A (en)
CA (1) CA1069888A (en)
CH (1) CH613186A5 (en)
DE (1) DE2438350C3 (en)
DK (1) DK148905C (en)
FR (1) FR2281132A1 (en)
GB (1) GB1523623A (en)
IE (1) IE41510B1 (en)
IL (1) IL47880A (en)
LU (1) LU73166A1 (en)
NL (1) NL182051C (en)
SE (2) SE424184B (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2617646C2 (en) * 1976-04-22 1986-07-31 Hoechst Ag, 6230 Frankfurt Nonapeptide-amides and decapeptide-amides with gonadoliberin activity, processes for their preparation and pharmaceutical preparations containing these compounds
GB1524747A (en) * 1976-05-11 1978-09-13 Ici Ltd Polypeptide
DE2735515A1 (en) * 1977-08-06 1979-02-22 Hoechst Ag USE OF LH-RH PEPTIDES AS AN ANTICONCEPTIVE
FR2450109B1 (en) * 1977-11-08 1986-03-28 Roussel Uclaf NOVEL TREATMENT METHOD USING LH-RH, OR AGONISTS
IT1149971B (en) * 1979-06-11 1986-12-10 Syntex Inc NONAPEPTIDE AND DECAPEPTIDE DERIVATIVES OF THE HORMONE THAT RELEASES THE LUTEINIZING HORMONE
US4234571A (en) * 1979-06-11 1980-11-18 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
DE3020941A1 (en) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt NONAPEPTIDE, METHOD FOR THE PRODUCTION THEREOF, AND ITS USE
HU185535B (en) * 1982-05-25 1985-02-28 Mta Koezponti Hivatala Process for preparing new gonadoliberin derivatives
HU187503B (en) * 1983-03-29 1986-01-28 Magyar Tudomanyos Akademia,Hu Process for preparing gonadoliberine derivatives containing beta-aspartyl group
AT390066B (en) * 1983-03-29 1990-03-12 Richter Gedeon Vegyeszet Process for the preparation of novel gonadoliberin derivatives
DE3411224A1 (en) * 1984-03-27 1985-10-10 Hoechst Ag, 6230 Frankfurt METHOD FOR THE RACEMATAR PRODUCTION OF INTERMEDIATE PEPTIDE PRODUCTS OF THE GONADORELIN AND GONADORELINANALOGA SYNTHESIS AND NEW INTERMEDIATE PRODUCTS IN THIS METHOD
US4775660A (en) * 1984-08-02 1988-10-04 Fernand Labrie Treatment of breast cancer by combination therapy
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
US4666885A (en) * 1985-02-08 1987-05-19 Fernand Labrie Combination therapy for treatment of female breast cancer
HU193093B (en) * 1985-04-16 1987-08-28 Innofinance Process for stimulating sexual activity of birds and domestic mammalians and process for producing spermatocytes for their propagation
HU194280B (en) * 1985-10-22 1988-01-28 Richter Gedeon Vegyeszet Process for producing new gonadoliberin analogues of high effectivity and pharmaceutical compositions containing them
DE69022722T2 (en) * 1989-03-10 1996-05-02 Endorecherche Inc., Ste-Foy, Quebec COMBINATION THERAPY FOR TREATING ESTROGEN SENSITIVE DISEASES.
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
JPH0235232A (en) * 1989-06-29 1990-02-05 Nhk Spring Co Ltd Partition film between gas and liquid chamber of pressure vessel
DE69034035T2 (en) * 1989-07-07 2004-01-22 Endorecherche Inc., Ste-Foy METHOD FOR TREATING ANDROGEN DISEASES
EP0485392B1 (en) * 1989-07-07 1998-09-09 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity
CA2029018A1 (en) * 1989-11-01 1991-05-02 Robert P. Millar Analogues of gonadotropin releasing hormone
JPH0474770U (en) * 1990-10-31 1992-06-30
WO1993023053A1 (en) * 1992-05-21 1993-11-25 Endorecherche Inc. INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
US6242421B1 (en) 1997-11-06 2001-06-05 Richard Lloyd Bowen Methods for preventing and treating Alzheimer's disease
ES2154590B1 (en) 1999-05-20 2001-11-01 Lipotec Sa SOLID PHASE SYNTHESIS PROCEDURE
AR023940A1 (en) 2000-05-03 2002-09-04 Eriochem Sa PROCEDURE FOR THE PRODUCTION OF PROLONGED WATERPROOF PEPTIDE MICROCAPSULES IN WATER
JP2004535431A (en) * 2001-06-22 2004-11-25 サザン バイオシステムズ， インコーポレイテッド Zero-order long-term release coaxial implant
US20060287282A1 (en) * 2001-06-25 2006-12-21 Steiner Mitchell S Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
ATE498408T1 (en) * 2001-08-10 2011-03-15 Takeda Pharmaceutical GNRH AGONISTIC COMBINATION AGENTS
WO2003041739A1 (en) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Anticaner agents
US20030144203A1 (en) * 2001-12-19 2003-07-31 Voyager Pharmaceutical Corporation Methods for slowing senescence and treating and preventing diseases associated with senescence
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2218448B1 (en) 2002-12-13 2015-09-23 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
GB0307777D0 (en) * 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
ES2602273T3 (en) 2004-09-17 2017-02-20 Durect Corporation Prolonged local anesthetic composition containing Saib
US20090036435A1 (en) 2005-01-21 2009-02-05 Astex Therapeutics Limited Pharmaceutical Compounds
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US7942867B2 (en) * 2005-11-09 2011-05-17 The Invention Science Fund I, Llc Remotely controlled substance delivery device
EP2073803B1 (en) 2006-10-12 2018-09-19 Astex Therapeutics Limited Pharmaceutical combinations
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
PT2117521E (en) 2006-11-03 2012-09-10 Durect Corp Transdermal delivery systems comprising bupivacaine
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
RU2444525C2 (en) * 2010-06-09 2012-03-10 Закрытое Акционерное Общество "Фарм-Синтез" Method for synthesis nonapeptide ethylamide and intemediate compounds for synthesis thereof
US11576891B2 (en) 2010-06-16 2023-02-14 Endorecherche, Inc. Methods of treating or preventing estrogen-related diseases
EP2983468A4 (en) 2013-03-15 2016-09-07 Durect Corp Compositions with a rheological modifier to reduce dissolution variability
JP2023515918A (en) 2020-01-13 2023-04-17 デュレクト コーポレーション Sustained release drug delivery system with reduced impurities and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5726506B2 (en) * 1974-03-08 1982-06-04
US3914412A (en) * 1973-10-11 1975-10-21 Abbott Lab {8 Des{13 Gly{9 {0 10 -Gn{13 RH nonapeptide amide analogs in position 6 having ovulation-inducing activity
US3901872A (en) * 1974-03-13 1975-08-26 American Home Prod P-glu-his-trp-ser-tyr-d-pgl-leu-arg-pro-gly-nh' 2 'and intermediates
US3896104A (en) * 1974-05-22 1975-07-22 American Home Prod P-glu-his-trp-ser-tyr-d-lys-leu-arg-pro-gly-nh' 2 'and intermediates

Also Published As

Publication number Publication date
DE2438350A1 (en) 1976-02-26
JPS5761268B2 (en) 1982-12-23
FR2281132A1 (en) 1976-03-05
FR2281132B1 (en) 1979-09-14
IL47880A0 (en) 1975-11-25
AU8374475A (en) 1977-02-10
DK148905B (en) 1985-11-11
GB1523623A (en) 1978-09-06
DE2438350C3 (en) 1979-06-13
IE41510B1 (en) 1980-01-16
CH613186A5 (en) 1979-09-14
BE832310A (en) 1976-02-11
AT364093B (en) 1981-09-25
US4024248A (en) 1977-05-17
NL182051C (en) 1988-01-04
DK361875A (en) 1976-02-10
DK148905C (en) 1986-04-07
NL7509260A (en) 1976-02-11
IL47880A (en) 1978-10-31
NL182051B (en) 1987-08-03
SE7508926L (en) 1976-02-10
CA1069888A (en) 1980-01-15
JPS5148659A (en) 1976-04-26
SE7805545L (en) 1978-05-16
LU73166A1 (en) 1977-04-13
DE2438350B2 (en) 1978-10-26
ATA618975A (en) 1981-02-15
IE41510L (en) 1976-02-09

Similar Documents

Publication Publication Date Title
SE424184B (en) PROCEDURE FOR PREPARING PEPTIDES WITH POWERFUL LH-RH / FSH-RH EFFECTS
SE423633B (en) PROCEDURE FOR PREPARING 4-DEMETOXY-DAUNOMYCINE
SE427752B (en) PROCEDURE FOR PREPARATION N-PHOSPHONOMETHYLGYLINE
SE428562B (en) PROCEDURE FOR PURINATE DERIVATIVES
SE421919B (en) PROCEDURE FOR PREPARING 2-TETRAHYDROFURFURYL-6,7-BENZOMORPHANES
SE7508406L (en) PROCEDURE FOR PREPARING POLYPHENYLENOXIDE.
SE7514456L (en) CORRECTOR
SE7513085L (en) PROCEDURE FOR THE PREPARATION OF ETRAR
SE431211B (en) PROCEDURE FOR PREPARING N-ACYLAMINO-ALFA-ARYLACETAMIDO-CEPHALOSPORINES
SE412066B (en) PROCEDURE FOR PREPARING PHAMACOLOGICALLY EFFECTIVE TIENODIAZINE DERIVATIVES
SE7506160L (en) PROCEDURE FOR THE PREPARATION OF N-CYCLOALKYLMETYLDEKAHYDROISOKINOLINE
SE421612B (en) PROCEDURE FOR PREPARING ALFA-6-DEOXI-5-HYDROXYTETRACYCLINE
SE421921B (en) ANALOGY PROCEDURE FOR PYRIDOBENSODIAZEPINON PREPARATION
SE418292B (en) PROCEDURE FOR PREPARING 5-ARYL-2-FURAMIDINES
NO147672C (en) ANALOGUE PROCEDURE FOR PREPARING N-ARYL-N- (1-L1-4-PIPERIDINYL) -ARYLACETAMIDES
SE400960B (en) PROCEDURE FOR PREPARING ALHŸ3 (POŸ4) Ÿ2 3HŸ2O
SE425739B (en) PROCEDURE FOR PREPARING CERTAIN STATED TETRAZOLYL-BENZOPYRANOPYRIDINE DERIVATIVES
SE7709806L (en) PROCEDURE FOR PREPARING PEPTIDES
SE414926B (en) PROCEDURE FOR PREPARING 1-ALKYL-2- (PHENOXIMETHYL) -5-NITROIMIDAZOLES
SE422202B (en) PROCEDURE FOR PREPARING AMIDOXIME DERIVATIVES
TR18782A (en) CATALIZOER IMALINE MAHSUS PROCEDURE
SE386664B (en) PROCEDURE FOR PREPARING CYSTINAL PEPTIDES
SE404364B (en) PROCEDURE FOR PREPARING CERTAIN 5-SULPHONYLPHENYL-TETRAZOLE DERIVATIVES
SE7511801L (en) PROCEDURE FOR THE PREPARATION OF IMPAMPOLYMERIZE
SE421310B (en) PROCEDURE FOR PREPARING SUBSTITUTED BENZOYLPYRIDINES

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7508926

SPCG Supplementary protection certificate granted

Free format text: 7508926, EXPIRES: 20000807

NAL Patent in force

Ref document number: 7508926-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7508926-8

Format of ref document f/p: F